Certus International, Inc.
Imaging CRO specializing in designing and conducting clinical trials.
Certus International, Inc. operates as an integrated contract research organization and core imaging services company in the United States. Offering trial management, consulting, imaging and biomarker research and QA services to pharmaceutical, biotechnology, and medical device companies. The company focuses on imaging clinical trials, including clinical research, biostatistics, regulatory consulting, data management, and the core imaging components necessary for demanding study protocols. Certus offers clinical services, regulatory expertise, and biomarker radiochemistry and synthesis services. The company focuses on clinical trials utilizing magnetic resonance imaging, computerized tomography, positron emission tomography, nuclear medicine, ultrasound and angiography, for diagnostic and therapeutic trials in oncology, cardiology, and neurology. The company was founded in 1995 and is based in St. Louis, MO with offices in Bedford, New Hampshire.